Search Results for: interactions

Treatment of HIV-2

Lead author: Sanjiv S. Shah, MD, MPH, AAHIVS, with the Medical Care Criteria Committee; October 2021 RECOMMENDATIONS Table 1: Preferred ART Regimens for Initial Treatment of Nonpregnant Adults With HIV-2 [a] (listed alphabetically; for specific details, see drug package inserts; for full recommendations on initiating ART in patients with HIV, see the NYSDOH AI guideline Selecting … Continue reading “Treatment of HIV-2”

General Principles in Choosing a Regimen for Rapid ART Initiation

Lead authors: Asa Radix, MD, MPH, and Noga Shalev, MD, with the Medical Care Criteria Committee, updated October 2021 RECOMMENDATIONS SELECTED GOOD PRACTICE REMINDERS Choosing a Regimen for Rapid ART Initiation The preferred medications for rapid ART initiation are based on the established regimens for individuals who are ART-naive and are restricted to those that … Continue reading “General Principles in Choosing a Regimen for Rapid ART Initiation”

Benefits and Risks of ART

Lead authors: Asa Radix, MD, MPH, and Noga Shalev, MD, with the Medical Care Criteria Committee, updated October 2021 RECOMMENDATION Antiretroviral therapy (ART) refers to the use of pharmacologic agents that have specific inhibitory effects on HIV replication. The use of fewer than three agents is not recommended for initiating rapid treatment. These agents belong … Continue reading “Benefits and Risks of ART”

ART-Initiation Laboratory Testing

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir ATV: atazanavir BIC: bictegravir COBI: cobicistat DOR: doravirine DRV: darunavir DTG: dolutegravir EFV: efavirenz EVG: elvitegravir FTC: emtricitabine RPV: rilpivirine RTV: ritonavir TAF: tenofovir alafenamide TDF: tenofovir disoproxil fumarate TMP-SMX: … Continue reading “ART-Initiation Laboratory Testing”

Special Considerations for Comorbid Conditions

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir ATZ: atazanavir BIC: bictegravir COBI: cobicistat DRV: darunavir DTG: dolutegravir EVG: elvitegravir FTC: emtricitabine LPV: lopinavir RAL: raltegravir RPV: rilpivirine RTV: ritonavir TAF: tenofovir alafenamide TDF: tenofovir disoproxil fumarate ART: … Continue reading “Special Considerations for Comorbid Conditions”

Specific Factors to Consider and Discuss With Patients

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir ATV: atazanavir BIC: bictegravir COBI: cobicistat DOR: doravirine DRV: darunavir DTG: dolutegravir EFV: efavirenz EVG: elvitegravir FTC: emtricitabine RAL: raltegravir RAL HD: RAL high-dose RPV: rilpivirine RTV: ritonavir TAF: tenofovir … Continue reading “Specific Factors to Consider and Discuss With Patients”

General Considerations With Initial ART Regimens

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir COBI: cobicistat DRV: darunavir DTG: dolutegravir EFV: efavirenz EVG: elvitegravir FTC: emtricitabine IDV: indinavir RPV: rilpivirine RTV: ritonavir TAF: tenofovir alafenamide TDF: tenofovir disoproxil fumarate ZDV: zidovudine ART: antiretroviral therapy FDC: fixed-dose … Continue reading “General Considerations With Initial ART Regimens”

General Principles in Choosing an Initial ART Regimen

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir ATV: atazanavir BIC: bictegravir COBI: cobicistat DOR: doravirine DRV: darunavir DTG: dolutegravir EFV: efavirenz EVG: elvitegravir FTC: emtricitabine LPV: lopinavir RAL: raltegravir RAL HD: RAL high-dose RPV: rilpivirine RTV: ritonavir … Continue reading “General Principles in Choosing an Initial ART Regimen”

Available ART Regimens

Reviewed and updated: Antonio E. Urbina, MD, with the Medical Care Criteria Committee; October 2021 Note: The recommendations in this guideline pertain to initial antiretroviral therapy (ART) regimens for adults with HIV who are not pregnant. RECOMMENDATIONS Available Antiretroviral Agents and Regimens Abbreviations used in this section: Drug names: Other: 3TC: lamivudine ABC: abacavir BIC: bictegravir COBI: cobicistat DTG: … Continue reading “Available ART Regimens”

Purpose of This Guideline

Reviewed and updated: Antonio E. Urbina, MD; October 2021 Writing group: Joseph P. McGowan, MD, FACP, FIDSA; Steven M. Fine, MD, PhD; Rona Vail, MD; Samuel T. Merrick, MD; Asa Radix, MD, MPH, PhD; Christopher J. Hoffmann, MD, MPH; Charles J. Gonzalez, MD Committee: Medical Care Criteria Committee Date of original publication: January 2019 This guideline was … Continue reading “Purpose of This Guideline”